Pinpoint Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.35M Sell
33,170
-25,627
-44% -$2.58M 0.58% 25
2024
Q4
$5.25M Sell
58,797
-6,500
-10% -$572K 0.93% 21
2024
Q3
$5.47M Buy
65,297
+1,900
+3% +$150K 1.17% 12
2024
Q2
$4.88M Buy
63,397
+10,444
+20% +$764K 0.69% 24
2024
Q1
$3.63M Buy
+52,953
New +$3.4M 0.58% 29

Other funds holding BSX

Pinpoint Asset Management's BSX Position: Q1 2025 in Review

Pinpoint Asset Management reduced its Boston Scientific (BSX) stake by 44% in Q1 2025, selling an estimated $2.58M and leaving 33,170 shares worth $3.35M. The position accounts for 0.58% of the portfolio, ranked #25.

Pinpoint Asset Management first reported a position in BSX in Q1 2024 and has held it in 5 quarters since. The position peaked at $5.47M in Q3 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Pinpoint Asset Management held 33,170 shares of Boston Scientific worth $3.35M as of Q1 2025.
  • Pinpoint Asset Management sold 25,627 Boston Scientific shares in Q1 2025, an estimated $2.58M.
  • Boston Scientific made up 0.58% of Pinpoint Asset Management's portfolio in Q1 2025, its #25 holding.
  • Pinpoint Asset Management first reported a position in Boston Scientific in Q1 2024 and has held it in 5 quarters since.
  • Pinpoint Asset Management's Boston Scientific position peaked at $5.47M in Q3 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Pinpoint Asset Management's 13F filing for Q1 2025, filed 12 May 2025.